ADR News Bulletin 2010 August (Volume 12 Number 2)
Healthcare professional
Industry member
Therapeutic Products
1 August 2010
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Bupivacaine (Marcain®) and reports of lack of efficacy
Zoledronic acid (Aclasta®) and rare reports of renal impairment
Orlistat and post-marketing reports of severe liver injury
Communication channels for drug safety information and updates
HSA hosts pharmacovigilance training for ASEAN countries
Intravascular haemolysis associated with WinRho® SDF injection
Summary on the findings of porcine circovirus DNA fragments in human rotavirus vaccines
Click on the link below to download the issue in pdf:
